EnsiliTech

EnsiliTech develops a patent-protected technology called Ensilication that encases thermally unstable biomolecules within a silica network to prevent degradation at temperatures ranging from –80 to +50°C. This method eliminates the need for cold-chain logistics for vaccines, antibodies, and other biological therapeutics used in human and animal health. The technology is designed to improve shelf-life and increase the global accessibility of diagnostics and biopharmaceutical formulations without using lyophilisation.